Research ghostwriting common, insiders say
Researchers are lending their names to reports written by ghostwriters hired by pharmaceutical companies to promote their product. This happened with Merck and Vioxx, but some say it's fairly common.
It's a disservice to real researchers, a disservice to science, and most of all, a disservice to patients whose doctors rely on studies to know whether and how to prescribe medications.
I hope some change comes out of this.
No comments:
Post a Comment